SCHEDULE: Brandes Investment Partners Boosts Utah Medical Stake
Beneficial Ownership Report
Brandes Investment Partners, L.P. has reported a 10.4% beneficial ownership stake in Utah Medical Products Inc., holding 333,204 common shares.
Summary
- Brandes Investment Partners, L.P. reported beneficial ownership of 333,204 common shares in Utah Medical Products Inc.
- This ownership represents 10.4% of the total common shares outstanding for Utah Medical Products Inc.
- Brandes Investment Partners, L.P. holds shared voting power over 286,784 shares.
- Brandes Investment Partners, L.P. holds shared dispositive power over all 333,204 shares.
- The filing is an Amendment No. 2 to a Schedule 13G, indicating an update to a previous ownership disclosure.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 6
Explanation: The filing indicates a significant institutional investor, Brandes Investment Partners, L.P., holds a substantial stake in Utah Medical Products Inc., which can be interpreted as a positive signal of confidence in the company's prospects. However, as a disclosure filing, it does not contain operational or financial performance data.
Positives
- Significant institutional ownership by Brandes Investment Partners, L.P. (10.4%) may signal confidence in Utah Medical Products Inc.'s long-term prospects.
- The investment is stated to be in the ordinary course of business, not for control, suggesting a passive, long-term investment perspective from a reputable investment firm.
Future Outlook
No forward-looking statements or guidance are provided in this beneficial ownership report.
Industry Context
Increased institutional ownership in a medical products company like Utah Medical Products Inc. can be viewed positively, as it often indicates a professional assessment of the company's market position, product pipeline, or financial stability within the healthcare sector. Such disclosures can attract further investor interest.
Stakeholder Impact
- Shareholders may view the significant stake by Brandes Investment Partners, L.P. as a vote of confidence, potentially influencing market perception and share price positively.
- The company's management might interpret this institutional investment as validation of their current strategy or operational performance.
Key Dates
| Date | Description |
|---|---|
| 08/31/2025 | Date of the event which required the filing of this statement. |
| 09/02/2025 | Date the Schedule 13G statement was signed by Brandes Investment Partners, L.P. |
Keywords
Utah Medical Products Inc, Brandes Investment Partners, Schedule 13G, beneficial ownership, institutional investment, common shares, medical products, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.